Reversal of severe hepatitis with infliximab in adult-onset still's disease

Bhavneet Singh; John Biboa; Sunitha Musuku; Charmi Patel; Judith L. Pugh; Thomas D. Boyer

doi:10.1016/j.amjmed.2012.08.003

Reversal of severe hepatitis with infliximab in adult-onset still's disease

Bhavneet Singh
, John Biboa
, Sunitha Musuku
, Charmi Patel
, Judith L. Pugh
, Thomas D. Boyer

Medicine

Research output: Contribution to journal › Letter › peer-review

9 Scopus citations

Original language	English (US)
Pages (from-to)	e3-e4
Journal	American Journal of Medicine
Volume	126
Issue number	2
DOIs	https://doi.org/10.1016/j.amjmed.2012.08.003
State	Published - Feb 2013

ASJC Scopus subject areas

General Medicine

Access to Document

10.1016/j.amjmed.2012.08.003

Cite this

@article{2ab2f8318118459f9026edfee5625503,

title = "Reversal of severe hepatitis with infliximab in adult-onset still's disease",

author = "Bhavneet Singh and John Biboa and Sunitha Musuku and Charmi Patel and Pugh, \{Judith L.\} and Boyer, \{Thomas D.\}",

year = "2013",

month = feb,

doi = "10.1016/j.amjmed.2012.08.003",

language = "English (US)",

volume = "126",

pages = "e3--e4",

journal = "American Journal of Medicine",

issn = "0002-9343",

publisher = "Elsevier Inc.",

number = "2",

}

TY - JOUR

T1 - Reversal of severe hepatitis with infliximab in adult-onset still's disease

AU - Singh, Bhavneet

AU - Biboa, John

AU - Musuku, Sunitha

AU - Patel, Charmi

AU - Pugh, Judith L.

AU - Boyer, Thomas D.

PY - 2013/2

Y1 - 2013/2

UR - https://www.scopus.com/pages/publications/84872513820

UR - https://www.scopus.com/pages/publications/84872513820#tab=citedBy

U2 - 10.1016/j.amjmed.2012.08.003

DO - 10.1016/j.amjmed.2012.08.003

M3 - Letter

C2 - 23331455

AN - SCOPUS:84872513820

SN - 0002-9343

VL - 126

SP - e3-e4

JO - American Journal of Medicine

JF - American Journal of Medicine

IS - 2

ER -

Reversal of severe hepatitis with infliximab in adult-onset still's disease

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this